![Memorial Sloan Kettering hematologic oncologist Ariela Noy](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/node/459/image/noy-ariela.jpg?h=10d202d3)
Ariela Noy, MD
Lymphoma Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Hodgkin and Non-Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Castleman's Disease, AIDS-related cancers
Request an Appointment
About Me
- Attending Physician
I am a board-certified medical oncologist and hematologist who cares for people with Hodgkin and non-Hodgkin lymphoma as well as other cancers of the lymphoid immune system. I have been practicing at MSK since 1997. I am part of a tight-knit team of experts who provide the best care for our patients.
Read more
My determination to help people with blood cancer began when I was in seventh grade and read a biography about a cancer researcher at MSK. Since then, cancer care and research have been my calling. It is my goal to make sure my patients feel well cared for. At MSK, our team of doctors, nurses, social workers, and other staff are strong proponents of patient education. We understand that a cancer diagnosis, whether it is new or cancer that has come back, is scary. We break down the information for our patients so they can get through it one day at a time. We want to take care of the details so our patients can concentrate on healing.
My research interests focus on new treatments, imaging, and quality of life related to lymphoma. In the past few years, many new drugs and therapies have evolved. For example, targeted therapies don’t suppress the immune system nearly as much as older drugs do. That means there is less risk of a patient becoming ill during treatment. In my own work, I evaluated ibrutinibas as a nontraditional and more targeted treatment option for marginal zone lymphoma. This work led to the US Food and Drug Administration’s approval. Other promising advances include sophisticated immune therapies, such as checkpoint inhibitors and chimeric antigen receptor T cell therapy.
In addition to my clinical and research work at MSK, I have served as Chair of the Lymphoma Working Group for the AIDS Malignancy Consortium, a National Cancer Institute–sponsored research group. I also served on the National Institutes of Health committee that oversaw the national cooperative group lymphoma research agenda, and I have contributed to the national guidelines for lymphoma treatment.
At MSK, I serve on several committees, including the Quality Assurance Committee for both the Department of Medicine and the Department of Radiology, the Fertility Preservation Committee, and others. I also enjoy my role as a mentor to students from the high school to postgraduate level.
Outside of MSK, I am really blessed to have New York City’s cultural life as my playground. I practice Ashtanga yoga every day, sing in a chamber choir, and paint in my studio. I would like to learn about your interests to better serve your needs.
A lymphoma specialist is a doctor with special training in diagnosing and treating lymphoma.
My Specialties
- Hodgkin and Non-Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Castleman's Disease, AIDS-related cancers
Education
- MD, University of Pennsylvania
Residencies
- Internal Medicine - Columbia Presbyterian Medical Center
Fellowships
- Hematology/Medical Oncology - Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College
Board Certifications
- Hematology
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
![Women talking](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/paragraph/131881/cta_image/app-220128-006_rt_1200x800.jpeg?h=10d202d3)
New Patients
Current Patients
Contact and Location
Dr. Noy sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Noy
- A Study of Daratumumab plus EPOCH Chemotherapy to Treat Plasmablastic Lymphoma
- AIDS Malignancy Consortium 101: A Pilot Study to Assess Adding Ibrutinib to Standard R-EPOCH Treatment for AIDS-Related Lymphomas
- Clinical Trials Co-Investigated by Dr. Noy
- A Long-Term Study of Sexual and Reproductive Health in Women with Breast Cancer and Lymphoma
- A Phase 1 Study of CAR T Cell Therapy for People with HIV and B Cell Lymphoma
Read more
![Smiling doctors in the lab](/themes/mskcc/images/clinicaltrials_small.png)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Noy’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Ariela Noy discloses the following relationships and financial interests:
-
ADC Therapeutics
Professional Services and Activities -
AstraZeneca
Professional Services and Activities -
BeiGene, Ltd.
Professional Services and Activities -
ClearView Healthcare Partners
Professional Services and Activities -
Dava Oncology
Professional Services and Activities (Uncompensated) -
Epizyme
Professional Services and Activities -
EUSA Pharma
Professional Services and Activities -
ExpertConnect
Professional Services and Activities -
Gerson Lehrman Group
Professional Services and Activities -
Guidepoint Global Advisors
Professional Services and Activities
-
Health Advances LLC
Professional Services and Activities -
Janssen Global Services, LLC
Professional Services and Activities -
Medallion Healthcare
Professional Services and Activities -
NSCI Group, Inc.
Professional Services and Activities -
OncLive
Professional Services and Activities -
PER Events, LLC
Professional Services and Activities -
Raphael Pharmaceuticals
Professional Services and Activities -
Recordati S.p.A.
Professional Services and Activities -
Slingshot Insights
Professional Services and Activities -
Techspert.io Ltd.
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].